previous reference ID: 22 next reference

CandActCFTR used public reference

The following publication reference has been reported to contain CFTR related structural information.
"M Chestnut" "JC Kappes" "CM McNicholas" "S Zhang" "EJ Sorscher" "AC Blount" "DF Skinner" "BA Woodworth"


Below you will find all the structures identified in the publication. Be warned that this does not imply any activity. n=2

ID: 5
InChIKey: LUKBXSAWLPMMSZ-OWOJBTEDSA-N
SMILES: C1=CC(=CC=C1/C=C/C2=CC(=CC(=C2)O)O)O

biological descriptors:

CFTR relevance: CFTR corrector

Category:
Influence on CFTR function enhances CFTR function
Order of interaction unknown
subcellular compartment Apical membrane & subapical compartment

chemical graph of compound 5



CID is 445154
synonyms found at PubChem are:
resveratrol, 501-36-0, trans-resveratrol, 3,4',5-Trihydroxystilbene, (E)-5-(4-Hydroxystyryl)benzene-1,3-diol, 3,5,4'-Trihydroxystilbene, (E)-resveratrol, 3,4',5-Stilbenetriol, Resvida, 3,4',5-Trihydroxy-trans-stilbene, 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol, SRT-501, SRT501, Resveratol, SRT 501, 3,5,4'-Trihydroxy-trans-stilbene, 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol, 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol, 3,4',5-trihydroxy-stilbene, Resveratrol, natural, UNII-Q369O8926L, CHEBI:45713, trans-3,4',5-trihydroxystilbene, (E)-5-(p-Hydroxystyryl)resorcinol, trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene, 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol, CHEMBL165, NSC 327430, (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol, MLS000069735, 1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)-, LUKBXSAWLPMMSZ-OWOJBTEDSA-N, KUC104385N, PREVENTION 8 (RESVERATROL), C14H12O3, trans-3,4',5 - trihydroxystilbene, NSC327430, KSC-10-164, Q369O8926L, 5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol, RM-1812, trans-3,4′,5-Trihydroxystilbene, SMR000058206, R 5010, DSSTox_CID_11980, DSSTox_RID_78898, DSSTox_GSID_31980, CU-01000001503-3, (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol, (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol, 1,3-Benzenediol, 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-, MFCD00133799, STL, SR-01000000163, 5-[(1E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol, CHEBI:27881, CCRIS 8952, HSDB 7571, 3fts, 4jaz, 4qer, Resveratrol, E-, Resveratrol,(S), Stilbene, 2f, TaxusChinensisiRehd, NCGC00015894-02, CAS-501-36-0, Prestwick_619, Trans-3,4&prime, Resveratrol, trans-, Resveratrol, synthetic, Opera_ID_586, AC1L9HIC, Prestwick2_000508, Prestwick3_000508, Spectrum5_000552, D0U3EP, Lopac0_001111, REGID_for_CID_6240, SCHEMBL19425, BSPBio_000435, BSPBio_001114, BSPBio_003461, MLS001055357, MLS001076538, MLS001424228, MLS002207121, MLS002222231, ARONIS24568, SPECTRUM1502223, BPBio1_000479, cid_445154, GTPL8741, SGCUT00007, trans-Stilbene-3,4',5-triol, ZINC6787, Resveratrol, analytical standard, DTXSID4031980, REGID_for_CID_445154, BDBM23926, Resveratrol, >=99% (HPLC), BBC/741, BIK9013, 2l98, MolPort-002-499-801, BCPP000091, HMS1362H15, HMS1569F17, HMS1792H15, HMS1921N04, HMS1990H15, HMS2052I09, HMS2096F17, HMS2232A18, HMS3263O04, HMS3403H15, HMS3649A20, ACT09778, BCP01416, to_000079, ZX-AS004941, ZX-AT013797, Tox21_110257, Tox21_201374, Tox21_303376, Tox21_501111, ABP000376, AC-727, AN-865, BBL028252, BS0159, CCG-38874, CR-003, GP2549, GP5884, LMPK13090005, s1396, SBB055452, STL146386, AKOS005720936, Tox21_110257_1, ACN-034773, API0000480, CS-1050, DB02709, KS-5047, LP01111, LS-2146, MCULE-5678456463, NC00349, NSC-327430, OR46018, RP17549, SDCCGMLS-0002998.P003, IDI1_002152, Resveratrol solution, 100 mM in DMSO, NCGC00017352-05, NCGC00017352-06, NCGC00017352-07, NCGC00017352-08, NCGC00017352-09, NCGC00017352-10, NCGC00017352-11, NCGC00017352-12, NCGC00017352-13, NCGC00017352-14, NCGC00017352-15, NCGC00017352-16, NCGC00017352-17, NCGC00017352-18, NCGC00017352-19, NCGC00017352-24, NCGC00024003-00, NCGC00024003-04, NCGC00024003-05, NCGC00024003-06, NCGC00024003-07, NCGC00024003-08, NCGC00024003-09, NCGC00024003-10, NCGC00024003-11, NCGC00024003-12, NCGC00024003-13, NCGC00024003-14, NCGC00257465-01, NCGC00258925-01, NCGC00261796-01, 375823-41-9, 4CN-0696, AJ-08292, AK-39118, AS-12413, BC202036, BR-39118, CC-34242, CJ-00111, CPD000058206, HY-16561, KB-02515, SAM001246888, SC-11924, ST057251, SY014849, ZB000650, AB0006623, AX8004672, ST2408097, TL8003323, EU-0101111, FT-0082623, N1848, R0071, Resveratrol, Vetec(TM) reagent grade, 98%, 01R360, C03582, J10118, N88795, 5-[2-(4-hydroxyphenyl)vinyl]-1,3-benzenediol, AB00052942-29, AB00052942_31, A827984, 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzoldiol, I06-0437, SR-01000000163-3, SR-01000000163-4, SR-01000000163-9, 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol, 5-[(E)-2-(4-Hydroxyphenyl)ethenyl]benzol-1,3-diol, 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzenediol, 5[(E)-2-(4-Hydroxyphenyl)-vinyl]benzene 1,3-diol, BRD-K25591257-001-01-2, BRD-K80738081-001-06-2, BRD-K80738081-001-07-0, BRD-K80738081-001-09-6, BRD-K80738081-001-10-4, BRD-K80738081-001-23-7, SR-01000000163-10, SR-01000000163-11, SR-01000000163-16, (E)-1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene, (E)1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene, 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3,benzenediol, Resveratrol, certified reference material, TraceCERT(R), 1,3-Benzenediol, 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-, Resveratrol, European Pharmacopoeia (EP) Reference Standard, 533C1DA0-4104-42B5-9D32-9265F40857E4, trans-Resveratrol, United States Pharmacopeia (USP) Reference Standard, 3,4',5-Trihydroxy-trans-stilbene 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol, (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol, InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1, trans-3,5,4'-Trihydroxystilbene3,4',5-Stilbenetrioltrans-Resveratrol(E)-5-(p-Hydroxystyryl)resorcinol(E)-5-(4-hydroxystyryl)benzene-1,3-diol

ID: 17
InChIKey: LUKBXSAWLPMMSZ-UPHRSURJSA-N
SMILES: C1=CC(=CC=C1/C=C\C2=CC(=CC(=C2)O)O)O

biological descriptors:

CFTR relevance: CFTR potentiator

Category:
Influence on CFTR function enhances CFTR function
Order of interaction unknown
subcellular compartment Apical membrane & subapical compartment

chemical graph of compound 17



CID is 1548910
synonyms found at PubChem are:
cis-resveratrol, (Z)-resveratrol, 61434-67-1, Cis resveratrol, Resveratrol, (Z)-, UNII-AUA0K06FSB, cis-3,4',5-trihydroxystilbene, AUA0K06FSB, CHEMBL87333, CHEBI:36002, 5-[(Z)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol, 5-[(Z)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol, 5-[(1Z)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol, 1,3-Benzenediol, 5-((1Z)-2-(4-hydroxyphenyl)ethenyl)-, Resveratrol (Z)-form [MI], Z-Resveratrol, Resveratrol, Z-, NCGC00015894-02, CAS-501-36-0, Tocris-1418, AC1LU7HY, Lopac-R-5010, cis-3,4,5-Trihydroxystilbene, SCHEMBL1931746, cis-3,5,4'-trihydroxystilbene, LUKBXSAWLPMMSZ-UPHRSURJSA-, (Z)-3,4',5-trihydroxystilbene, (Z)-3,5,4'-trihydroxystilbene, 4q93, MolPort-003-850-143, TNP00294, 1684AH, BDBM50131698, ZINC12353732, AKOS025395422, NCGC00015894-01, NCGC00017352-01, NCGC00017352-02, NCGC00017352-03, NCGC00017352-04, NCGC00024003-02, AC-24235, CJ-13797, DB-072954, 434C671, I14-7425, Z-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol, cis-5-[2-(4-Hydroxyphenyl)ethenyl]benzene-1,3-diol, 05F9DB2A-D7E6-4063-8E5B-F7842CF74A5E, 5-[(1Z)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol, InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1-